AU2003290393A8 - Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent - Google Patents

Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent

Info

Publication number
AU2003290393A8
AU2003290393A8 AU2003290393A AU2003290393A AU2003290393A8 AU 2003290393 A8 AU2003290393 A8 AU 2003290393A8 AU 2003290393 A AU2003290393 A AU 2003290393A AU 2003290393 A AU2003290393 A AU 2003290393A AU 2003290393 A8 AU2003290393 A8 AU 2003290393A8
Authority
AU
Australia
Prior art keywords
desferrioxamine
composition
metal complex
tissue damage
following exposure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290393A
Other versions
AU2003290393A1 (en
Inventor
Mordechai Chevion
Eduard Berenshtein
Eyal Banin
Alexey Obolensky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hadasit Medical Research Services and Development Co
Yissum Research Development Co of Hebrew University of Jerusalem
Original Assignee
Hadasit Medical Research Services and Development Co
Yissum Research Development Co of Hebrew University of Jerusalem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Research Services and Development Co, Yissum Research Development Co of Hebrew University of Jerusalem filed Critical Hadasit Medical Research Services and Development Co
Publication of AU2003290393A8 publication Critical patent/AU2003290393A8/en
Publication of AU2003290393A1 publication Critical patent/AU2003290393A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003290393A 2003-01-07 2003-12-31 Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent Abandoned AU2003290393A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL15383503 2003-01-07
IL153835 2003-01-07
PCT/IL2003/001122 WO2004060490A1 (en) 2003-01-07 2003-12-31 Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent

Publications (2)

Publication Number Publication Date
AU2003290393A8 true AU2003290393A8 (en) 2004-07-29
AU2003290393A1 AU2003290393A1 (en) 2004-07-29

Family

ID=32697011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290393A Abandoned AU2003290393A1 (en) 2003-01-07 2003-12-31 Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent

Country Status (2)

Country Link
AU (1) AU2003290393A1 (en)
WO (1) WO2004060490A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680148B2 (en) 2006-08-11 2014-03-25 University Of Washington Metallo-desferrioxamine complexes and their use in the treatment of bacterial infections
WO2008091829A1 (en) * 2007-01-23 2008-07-31 Lawrence Bernstein Ophthalmic gallium compositions and methods of their use
US20090187060A1 (en) 2008-01-22 2009-07-23 E-Z-Em, Inc. Method and Formulation for Neutralizing Toxic Chemicals and Materials
WO2011021203A2 (en) * 2009-08-19 2011-02-24 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Desferrioxamine-metal complexes for the treatment of immune-related disorders
SG11201704815VA (en) 2014-12-22 2017-07-28 Mordechai Chevion New metal complexes of nocardamine and their use in pharmaceutical compositions
JP7003045B2 (en) * 2016-02-11 2022-02-04 シェヴィオン モデハイ Methods and pharmaceutical compositions for the treatment of neurodegeneration
CN117065087A (en) * 2023-10-16 2023-11-17 中国人民解放军总医院第四医学中心 Preparation method and application of black phosphorus chitosan DFO temperature-sensitive hydrogel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5416078A (en) * 1990-03-30 1995-05-16 Biomedical Frontiers, Inc. Fluid resuscitation
IL106064A (en) * 1993-06-18 1997-11-20 Yissum Res Dev Co Gallium complexes for the treatment of free radical-induced diseases
NZ267484A (en) * 1994-06-27 1997-12-19 Ioannis Stavridis Use of metal ion-porphyrin ring complexes in cigarette filters

Also Published As

Publication number Publication date
WO2004060490A1 (en) 2004-07-22
AU2003290393A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
GB2421260B (en) Well treating compositions for slow release of treatment agents and methods of using the same
AU2003282358A1 (en) Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
HK1119060A1 (en) Parakeratosis inhibitor, pore-shrinking agent and external composition for skin
TWI349689B (en) Light-curable composition and coating agent composition
HK1097256A1 (en) Pyrizdazine derivatives and their use as therapeutic agents
AU2003284242A8 (en) Methods and compositions for use in treating cancer
PL372395A1 (en) Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
IL166475A (en) Use of glutamine or carbohydrate in the manufacture of a composition for protecting non-mucosal tissue against damage from radiation therapy
EP1613266A4 (en) Methods of treating pain and compositions for use therefor
HK1116686A1 (en) Formulations and methods for treating amyloidosis
EP1736173A4 (en) Damaged tissue therapeutic agent and therapeutic method
EP1933853A4 (en) Tissue disruption treatment and composition for use thereof
EP1954800A4 (en) Composition and use of phyto-percolate for treatment of disease
EP1928247A4 (en) Composition and use of phyto-percolate for treatment of disease
EP1840948A4 (en) Fine treatment agent and fine treatment method using same
EP1688126A4 (en) Parakeratosis inhibitor and external composition for skin
AU2003290393A8 (en) Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent
EP1666663A4 (en) Fabric treating agent composition
SG110107A1 (en) Compound and use in treatment
GB2448442B (en) Well treating compositions for slow release of treatment agents and methods of using the same
EP1850827A4 (en) Composition for treating and preventing periodontal disease and method of use
AU2003275433A8 (en) Compositions and methods for treating pain
GB0405017D0 (en) Composition for use in the treatment of dry skin conditions
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
IL157396A0 (en) Use of lipophilic diesters of chelating agent for the treatment of amyloidosis and atherosclerosis

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 34, PAGE(S) 8928 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM, APPLICATION NO. 2003290393, UNDER INID (71) CORRECT THE NAME TO READ HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.; YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase